Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids

Chest

Volumn 110, Issue 2, 1996, Pages 367-370

  Kubiet, Martin A ^a   Gonzalez Rothi, Ricardo J ^a,b   Cottey, Rob ^a   Bender, Bradley S ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

antibody response; corticosteroids; influenza vaccine; pulmonary disease

Indexed keywords

INFLUENZA VACCINE;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; MALE; PRIORITY JOURNAL;

EID: 0029741450     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.2.367     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the immunization practices advisory committee (ACIP). MMWR 1994; 43 (No. RR-9):1-13
2. Baxter JD, Harris AW. Mechanism of glucocorticoid action: general features, with reference to steroid-mediated immunosuppression. Transplant Proc 1975; 7:55-65
3. Butler WT. Corticosteroids and immunoglobulin synthesis.Transplant Proc 1975; 7:49-53
4. Influenza virus vaccine, trivalent, types A and B. Marietta, Pa: Wyeth Laboratories, CI 4222-1; issued June 6, 1994
5. Tannock GA. Alternatives in the control of influenza. Med J Aust 1991; 154:692-95
6. US Dept of Health and Human Services. Influenza virus reagents for the hemagglutination inhibition test. Washington, DC: US Dept of Health and Human Services, 1991; 31:1-16
7. Salk JE. Simplified procedure for titrating hemagglutinating capacity of influenza virus and the corresponding antibody. J Immunol 1944; 49:87-98
8. Fauci AS. Immunosuppressive and anti-inflammatory effects of glucocorticoids. In: Baxter JD, Rousseau G. eds. Glucocorticoid hormone action. New York: Springer Verlag, 1979; 449-65
9. Forscid J, Hed J. In vitro effect of hydrocortisone on the attachment and ingestion phases of immunoglobulin G and complement component-3B mediated phagocytosis by human neutrophils. Infect Immun 1982; 38:811-15
10. Kelso A, Munck A. Glococorticoid inhibition of lymphokine secretion by alloreactive T lymphocyte clones. J Immunol 1984; 133:784-91
11. Herron A, Dettleff G, Hixon B, et al. Influenza vaccination in patients with rheumatic diseases - safety and efficacy. JAMA 1979; 242:53-6
12. Chalmers, A Scheifele D, Patterson C, et al. Immunization of patients with rheumatoid arthritis against influenza: a study of vaccine Safety and immunogenicity. J Rheumatol 1994; 21:1203-06
13. Gross RA, Gould AL, Brown AE. Effect of cancer chemotherapy on the immune response to influenza virus vaccine: review of published studies. Rev Infect Dis 1985; 7:613-18
14. Arden NH, Patriarca PA, Kendal AP. Experiences in the use and efficacy of inactivated influenza vaccine in nursing homes. Los Angeles: UCLA Symposia on Molecular and Cellular Biology, New Series; 1986; 36:155-68
15. Ochiai H, Shibata M, Kamimura K, et al. Evaluation of the efficacy of split-product trivalent A (H1N1), A (H3N2) and B influenza vaccines: protective efficacy. Microbiol Immunol 1986; 30:1151-65
16. Sugiura A, Yanagawa H, Enomoto C, et al. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2/Hong Kong and B influenza viruses. J Infect Dis 1970; 122:472-78
17. Foy HM, Allan I, Blumhagen JM, et al. A/USSR and B/Hong Kong vaccine: field experiences during an A/Brazil and an influenza B epidemic. JAMA 1981; 245:1736-40
18. Lahood N, Emerson SS, Kumar P, et al. Autibody levels and response to pneumococcal vaccine in steroid-dependent asthma. Ann Allergy 1993; 70:289-94
19. Zei T, Neri M, Iorio AM. Immunogenicity of trivalent subunit and split influenza vaccine (1989-90 winter season) in volunteers of different age groups. Vaccine 1991; 9:613-17
20. Zuckerman MA, Wood J, Chakraverty P, et al. Serological responses in volunteers to inactivated trivalent subunit influenza vaccine: antibody reactivity with epidemic influenza A and B strains and evidence of a rapid immune response. J Med Virol 1991; 33:133-37